| Kenneth Bookman, MD | |
|
3021 Airport Pulling Rd N, Suite 103, Naples, FL 34105-3077 | |
| (239) 421-3700 | |
| (239) 430-7824 |
| Full Name | Kenneth Bookman |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 25 Years |
| Location | 3021 Airport Pulling Rd N, Naples, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881792349 | NPI | - | NPPES |
| 16528 | Other | FL | BCBS |
| 273218100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME92562 (Florida) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | ME92562 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Preferred Care Home Health Services | Fort myers, FL | Home health agency |
| Naples Community Hospital | Naples, FL | Hospital |
| Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Naples Pulmonary Llc | 4789014143 | 2 |
News Archive
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Arizona State University researchers to date have received more than $32 million in stimulus package research grants. For ASU, which has played a very active role in attracting this additional funding, much of these research funds have gone for projects that meet challenges currently confronting society.
› Verified 1 days ago
| Entity Name | Naples Pulmonary Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104464262 PECOS PAC ID: 4789014143 Enrollment ID: O20200427000677 |
News Archive
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Arizona State University researchers to date have received more than $32 million in stimulus package research grants. For ASU, which has played a very active role in attracting this additional funding, much of these research funds have gone for projects that meet challenges currently confronting society.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth Bookman, MD 3021 Airport-pulling Road No, St 103, Naples, FL 34105 Ph: (239) 208-0831 | Kenneth Bookman, MD 3021 Airport Pulling Rd N, Suite 103, Naples, FL 34105-3077 Ph: (239) 421-3700 |
News Archive
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on March 28, 2010, the Company's patent application for its proprietary Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavonoids Soft Capsules and related formulation method passed a preliminary review conducted by the State Intellectual Property Office of the People's Republic of China ("SIPO").
EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Arizona State University researchers to date have received more than $32 million in stimulus package research grants. For ASU, which has played a very active role in attracting this additional funding, much of these research funds have gone for projects that meet challenges currently confronting society.
› Verified 1 days ago
Ricardo Martinez, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 5th Ave N Ste 102, Naples, FL 34102 Phone: 239-315-7801 Fax: 855-888-3291 | |
Dr. Karen Moss Ezrine, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 762 Regency Reserve Cir, Naples, FL 34119 Phone: 239-354-1998 | |
Dr. Lawrence Kenneth Harris, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2171 Pine Ridge Rd, Suite F, Naples, FL 34109 Phone: 239-566-7425 Fax: 239-593-3430 | |
Todd David Brodie, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 730 Goodlette Rd N, Ste 205, Naples, FL 34102 Phone: 239-436-3666 Fax: 239-436-3678 | |
Dr. Frank Michael Elterman, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6101 Pine Ridge Rd, Naples, FL 34119 Phone: 239-330-2933 Fax: 855-691-0391 | |
Vincent Charles Bianca Iii, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 9015 Strada Stell Ct, Suite 201, Naples, FL 34109 Phone: 239-597-5638 Fax: 239-597-5628 | |
Catherine Nina Kowal, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1855 Veterans Park Dr, Suite 103, Naples, FL 34109 Phone: 239-596-5220 Fax: 239-643-9816 |